Getting into a research study is more straightforward than most people expect. The basic path involves searching a study database or registry, checking whether you meet the eligibility criteria, and contacting the research team. From there, you’ll go through a screening process and sign an informed consent form before anything begins. The specifics depend on the type of study, your health status, and how much time you can commit.
Where to Find Studies Accepting Participants
ClinicalTrials.gov is the largest public database of research studies and the best starting point. On the homepage, enter a condition or disease in the search field, add your city, state, or zip code, and select “Recruiting and not yet recruiting studies” to filter for studies currently accepting participants. You can narrow results further by age, sex, study phase, and whether the study accepts healthy volunteers. Every listing includes contact information for the research team.
If you’d rather let studies come to you, ResearchMatch is a free registry funded by the National Institutes of Health. You create a profile, answer a survey, and optionally share health information. The platform then emails you about studies that match your profile. It’s open to people of all ages and health backgrounds.
Large-scale programs also recruit directly. The NIH’s All of Us Research Program, for example, is building a health database from at least one million people over 10 or more years. Joining involves creating an account, completing a consent process (about 15 to 40 minutes), optionally sharing your electronic health records, filling out health surveys, and providing physical measurements or biological samples. There’s no cost to participate, and the program pays $25 for in-person sample visits.
Beyond these national resources, university medical centers, community hospitals, and advocacy organizations for specific conditions frequently post recruitment flyers and maintain their own registries. A quick search for your local academic medical center plus “clinical trials” will often turn up a dedicated recruitment page.
Understanding Eligibility Criteria
Every study has a list of inclusion criteria (what qualifies you) and exclusion criteria (what disqualifies you). These exist to protect your safety and to ensure the study produces reliable results. Common factors include age range, specific diagnosis, current medications, and medical history. A study might require that you’ve been on a stable dose of your current medication for 60 to 120 days, or that you don’t have certain conditions like heart failure, active cancer, or a history of major stroke.
Some studies require imaging scans, which means having a pacemaker or certain metal implants could rule you out. Others require a study partner, typically a spouse or close friend, who can attend visits with you and help with things like remembering appointments or tracking medication. Don’t assume you’re ineligible before checking. Criteria vary widely from one study to the next, and many are more flexible than they first appear.
What Healthy Volunteers Can Expect
You don’t need a medical condition to participate in research. Phase I trials specifically recruit healthy volunteers, typically 20 to 80 people, to test a new drug or treatment for the first time. The focus at this stage is entirely on safety: researchers want to understand how the body processes the substance and identify side effects before testing it in patients.
Screening for healthy volunteer studies tends to be thorough. Expect comprehensive lab work and a detailed medical history review. Some studies use registries or background checks to verify that volunteers aren’t enrolled in multiple trials simultaneously. Time commitments can be significant. Some Phase I trials require you to stay at the research facility for several days, follow dietary restrictions, or abstain from smoking. Compensation reflects this level of involvement and is generally higher than for studies with fewer demands on your time.
How Studies Progress Through Phases
If you’re considering a study, knowing which phase it’s in helps you understand what you’re signing up for. Phase I studies are small (20 to 80 people) and focused on safety. Phase II studies expand to 100 to 300 people and begin evaluating whether the treatment actually works, while continuing to monitor safety. Phase III studies are large, involving 1,000 to 3,000 participants, and compare the new treatment against existing standard treatments. Phase IV studies happen after a drug has already been approved and is on the market, tracking long-term safety and effectiveness in the general population.
Earlier phases carry more uncertainty because less is known about the treatment. Later phases involve treatments with a stronger safety record but may require a longer commitment and more frequent visits.
Your Rights as a Participant
Before you join any study, you’ll sign an informed consent document. Federal regulations require this document to include several specific things: a clear explanation of the study’s purpose and how long your participation will last, a description of every procedure involved, a plain-language summary of foreseeable risks and potential benefits, and information about how your privacy will be protected.
The consent form must also tell you whether compensation or medical treatment is available if you’re injured during the study, give you contact information for someone who can answer questions about your rights, and state explicitly that participation is voluntary. You can refuse to participate without any penalty, and you can withdraw at any time for any reason without losing benefits you’re otherwise entitled to. If significant new findings emerge during the study that might affect your willingness to continue, the research team is required to share them with you.
Informed consent isn’t a one-time event. You can ask questions before, during, and after signing, and pulling out never requires justification.
How Your Safety Is Protected
Every study involving human participants must be reviewed and approved by an Institutional Review Board before it begins. An IRB is an independent committee that evaluates the study’s design to make sure the risks to participants are minimized and reasonable relative to the expected benefits. The board reviews the study protocol, the informed consent document (checking that it’s written in language participants can actually understand), and the process for obtaining consent.
IRB oversight doesn’t end at approval. Any changes to the study protocol must go back to the board for review before they’re implemented, unless the change is needed immediately to protect participants from harm. The IRB also has the authority to observe the consent process or audit the study’s conduct if concerns arise.
Compensation and Costs
Most studies compensate participants for their time, inconvenience, and any discomfort involved. The amount varies enormously depending on what the study requires. A simple survey-based study might offer a small gift card, while a Phase I trial requiring days of confinement at a facility pays considerably more. Travel expenses, parking, and lodging are typically reimbursed separately and are not considered part of the study payment.
Federal guidelines require that payment accrues as the study progresses rather than being withheld until completion. A small bonus for finishing the entire study is permitted, but it can’t be large enough to pressure you into staying when you’d otherwise leave. The IRB reviews the payment structure before the study begins to make sure it’s fair and doesn’t cross the line into coercion.
Participation should never cost you money out of pocket for study-related procedures. If there are any additional costs you might incur, the consent form is required to disclose them.
Participating From Home
Not every study requires repeated trips to a research site. Decentralized trials allow some or all study activities to happen remotely. This can include telehealth visits with the research team, in-home visits from mobile health professionals, or visits with a local healthcare provider instead of the main study site. Some trials use wearable devices or smartphone apps to collect health data between visits, reducing the need for travel while still gathering the information researchers need.
When searching ClinicalTrials.gov, look for study descriptions that mention remote participation, virtual visits, or decentralized elements. These options have expanded significantly in recent years and make participation realistic for people who live far from major research centers or have limited mobility.